Tamoxifen stimulates phospholipase D activity by an estrogen receptor-independent mechanism

This publication has 26 references indexed in Scilit:

• Tamoxifen as Adjuvant Therapy in Breast Cancer
  Drugs, 1993
• Overview From the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer
  JNCI Journal of the National Cancer Institute, 1992
• Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin
  Biochemical Journal, 1992
• Endocrine Pharmacology of Antiestrogens as Antitumor Agents*
  Endocrine Reviews, 1990
• Multiple mechanisms of protein kinase C inhibition by triphenylacrylonitrile antiestrogens
  FEBS Letters, 1990
• The regulation and cellular functions of phosphatidylcholine hydrolysis
  Biochemical Journal, 1990
• Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicity
  Biochemical Pharmacology, 1990
• Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
  Cell, 1989
• Growth factor-like action of phosphatidic acid
  Nature, 1986
• Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
  Biochemical and Biophysical Research Communications, 1984